REDONNA was a single-blinded, two-arm clinical trial of a prescribing Portrait for eligible family physicians in British Columbia, Canada. It examined
Dennis McCarty receives prestigious Kentucky award 2022
Dennis McCarty, Ph.D., an Emeritus Professor in the School of Public Health at the Portland State University and Oregon Health & Science
Why inequality hinders effective pain relief for opioid naive people
Equitable access to care is problematic; some people get it, most are left out. The REDONNA study (https://doi.org/10.1016/j.cct.2021.106462) began
Newly started primary care opioid prescriptions plateaued in 2018-2019
Our new study published in the Canadian Journal of Addiction found plateauing rates of new starts of opioid analgesics in British Columbia in
Mentoring helps physicians publish more peer-reviewed papers, study says
Physician scientists help advance the science of addiction medicine, yet prior studies have not looked at better ways of increasing publication
Can stimulants treat stimulant use disorder?
This ‘systematic overview of reviews’ assembled the evidence for stimulant use disorder treatments from the systematic reviews of literature.
Can prescribers avoid contributing to opioid use disorder?
A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week
Why most opioid risk tools fail?
How many of you had a flu this winter? Anyone took antibiotics for that? But some people can’t take them because they are allergic. Now, imagine
As good as methadone if not better
Looking at an old drug repurposed to treat opioid addiction, a new study found long-acting formulation of morphine (SROM) promising for curbing the